Axogen ( NASDAQ: AXGN ) said it has appointed Michael Dale as its chief executive officer, effective August 9. Dale, who has over three decades of experience, will succeed Karen Zaderej, who will remain in an advisory role for nine months. The firm also named Paul Thomas as chair.
Thomas has been a member of the board since 2020. More on AxoGen Seeking Alpha’s Quant Rating on AxoGen Historical earnings data for AxoGen Financial information for AxoGen.
